Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1998 2
1999 1
2000 1
2003 1
2005 1
2006 1
2007 1
2008 3
2009 4
2010 3
2011 9
2012 5
2013 3
2014 3
2015 11
2016 7
2017 5
2018 12
2019 5
2020 5
2021 2
2022 4
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
EANO guideline on the diagnosis and treatment of vestibular schwannoma.
Goldbrunner R, Weller M, Regis J, Lund-Johansen M, Stavrinou P, Reuss D, Evans DG, Lefranc F, Sallabanda K, Falini A, Axon P, Sterkers O, Fariselli L, Wick W, Tonn JC. Goldbrunner R, et al. Neuro Oncol. 2020 Jan 11;22(1):31-45. doi: 10.1093/neuonc/noz153. Neuro Oncol. 2020. PMID: 31504802 Free PMC article.
Therefore, the vestibular schwannoma task force of the European Association of Neuro-Oncology assessed the data available in the literature and composed a set of recommendations for health care professionals. The radiological diagnosis of vestibular schwannoma is made by m …
Therefore, the vestibular schwannoma task force of the European Association of Neuro-Oncology assessed the data available in the literature …
Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation.
Plotkin SR, Messiaen L, Legius E, Pancza P, Avery RA, Blakeley JO, Babovic-Vuksanovic D, Ferner R, Fisher MJ, Friedman JM, Giovannini M, Gutmann DH, Hanemann CO, Kalamarides M, Kehrer-Sawatzki H, Korf BR, Mautner VF, MacCollin M, Papi L, Rauen KA, Riccardi V, Schorry E, Smith MJ, Stemmer-Rachamimov A, Stevenson DA, Ullrich NJ, Viskochil D, Wimmer K, Yohay K; International Consensus Group on Neurofibromatosis Diagnostic Criteria (I-NF-DC); Huson SM, Wolkenstein P, Evans DG. Plotkin SR, et al. Genet Med. 2022 Sep;24(9):1967-1977. doi: 10.1016/j.gim.2022.05.007. Epub 2022 Jun 9. Genet Med. 2022. PMID: 35674741 Free article.
PURPOSE: Neurofibromatosis type 2 (NF2) and schwannomatosis (SWN) are genetically distinct tumor predisposition syndromes with overlapping phenotypes. ...In addition, we recommend updated nomenclature for these disorders to emphasize their phenotypic overlap …
PURPOSE: Neurofibromatosis type 2 (NF2) and schwannomatosis (SWN) are genetically distinct tumor predisposition syndrom …
Medical management of meningiomas.
Chukwueke UN, Wen PY. Chukwueke UN, et al. Handb Clin Neurol. 2020;170:291-302. doi: 10.1016/B978-0-12-822198-3.00048-3. Handb Clin Neurol. 2020. PMID: 32586501 Review.
The mainstay of treatment has been the combination of radiation therapy and surgery, with a limited role for systemic therapy due to low efficacy, short duration of treatment response, and lack of uniform response criteria. Similar to other primary and metastatic br …
The mainstay of treatment has been the combination of radiation therapy and surgery, with a limited role for systemic therapy …
The Future of Vestibular Schwannoma Management.
Moore LS, Stankovic KM. Moore LS, et al. Otolaryngol Clin North Am. 2023 Jun;56(3):611-622. doi: 10.1016/j.otc.2023.02.018. Epub 2023 Apr 3. Otolaryngol Clin North Am. 2023. PMID: 37019772 Review.
The future of the management of both sporadic and neurofibromatosis type 2-asscoiated vestibular schwannomas (VSs) will be shaped by cutting-edge technologic and biomedical advances to enable personalized, precision medicine. This scoping review envisions the …
The future of the management of both sporadic and neurofibromatosis type 2-asscoiated vestibular schwannomas (VSs) will …
Management of Neurofibromatosis Type 2-Associated Vestibular Schwannomas.
Jiramongkolchai P, Schwartz MS, Friedman RA. Jiramongkolchai P, et al. Otolaryngol Clin North Am. 2023 Jun;56(3):533-541. doi: 10.1016/j.otc.2023.02.012. Epub 2023 Mar 22. Otolaryngol Clin North Am. 2023. PMID: 36964092 Review.
Neurofibromatosis type 2 (NF2) is an autosomal dominant syndrome caused by a mutation in the NF2 suppressor gene and is characterized by the development of multiple benign tumors throughout the central nervous system. Bilateral vestibular schwannomas (VSs) ar …
Neurofibromatosis type 2 (NF2) is an autosomal dominant syndrome caused by a mutation in the NF2 suppressor gene and is …
Neurofibromatosis: part 2--clinical management.
Batista PB, Bertollo EM, Costa Dde S, Eliam L, Cunha KS, Cunha-Melo JR, Darrigo Junior LG, Geller M, Gianordoli-Nascimento IF, Madeira LG, Mendes HM, Miranda DM, Mata-Machado NA, Morato EG, Pavarino ÉC, Pereira LB, Rezende NA, Rodrigues Lde O, Sette JB. Batista PB, et al. Arq Neuropsiquiatr. 2015 Jun;73(6):531-43. doi: 10.1590/0004-282X20150042. Arq Neuropsiquiatr. 2015. PMID: 26083891 Free article.
Part 1 of this guideline addressed the differential diagnosis of the neurofibromatoses (NF): neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2) and schwannomatosis (SCH). ...
Part 1 of this guideline addressed the differential diagnosis of the neurofibromatoses (NF): neurofibromatosis type 1 (NF1), …
Management of Central and Peripheral Nervous System Tumors in Patients with Neurofibromatosis.
Brown R. Brown R. Curr Oncol Rep. 2023 Dec;25(12):1409-1417. doi: 10.1007/s11912-023-01451-z. Epub 2023 Oct 31. Curr Oncol Rep. 2023. PMID: 37906356 Review.
Neurofibromatosis type I (NF1), neurofibromatosis type 2 (NF2), and schwannomatosis represent a diverse group of genetic tumor predisposition syndromes with a shared feature of tumors affecting the peripheral nerve sheaths. ...RECENT FINDINGS: M …
Neurofibromatosis type I (NF1), neurofibromatosis type 2 (NF2), and schwannomatosis represent a diverse g …
Clinical practice guideline on the management of vestibular schwannoma.
Lassaletta L, Acle Cervera L, Altuna X, Amilibia Cabeza E, Arístegui Ruiz M, Batuecas Caletrio Á, Benítez Del Rosario J, Cabanillas Farpón R, Costales Marcos M, Escada P, Espinosa-Sánchez JM, García Leal R, Gavilán J, Gómez Martínez J, González-Aguado R, Martinez-Glez V, Guerra Jiménez G, Harguindey Antolí-Candela A, Hernández García BJ, Orús Dotú C, Polo López R, Manrique M, Martín Sanz E, Martínez Álvarez R, Martínez H, Martínez-Martínez M, Rey-Martinez J, Ropero Romero F, Santa Cruz Ruiz S, Vallejo LÁ, Soto Varela A, Varela-Nieto I, Morales Puebla JM. Lassaletta L, et al. Acta Otorrinolaringol Esp (Engl Ed). 2024 Mar-Apr;75(2):108-128. doi: 10.1016/j.otoeng.2023.10.005. Epub 2024 Feb 10. Acta Otorrinolaringol Esp (Engl Ed). 2024. PMID: 38346489
Taking into account the characteristics of the tumour, the symptoms and the age of the patient, three therapeutic strategies have been proposed: observation, surgery or radiotherapy. ...The absence of sufficient prospective studies means that the levels of evidence on the …
Taking into account the characteristics of the tumour, the symptoms and the age of the patient, three therapeutic strategies have bee …
An update on the diagnosis and treatment of vestibular schwannoma.
Halliday J, Rutherford SA, McCabe MG, Evans DG. Halliday J, et al. Expert Rev Neurother. 2018 Jan;18(1):29-39. doi: 10.1080/14737175.2018.1399795. Epub 2017 Nov 7. Expert Rev Neurother. 2018. PMID: 29088993 Review.
Most are sporadic, with approximately 5% related to the tumor predisposition syndrome Neurofibromatosis Type 2 (NF2). The mainstays of management strategies are: observation, surgery, radiosurgery/radiotherapy and, for patients with NF2 and rapidly growing tu …
Most are sporadic, with approximately 5% related to the tumor predisposition syndrome Neurofibromatosis Type 2 (NF2). T …
Neurofibromatosis type 2 (NF2): diagnosis and management.
Lloyd SK, Evans DG. Lloyd SK, et al. Handb Clin Neurol. 2013;115:957-67. doi: 10.1016/B978-0-444-52902-2.00054-0. Handb Clin Neurol. 2013. PMID: 23931824 Review.
Neurofibromatosis type 2 (NF2) is an autosomal dominant inherited tumor predisposition syndrome caused by mutations in the NF2 gene on chromosome 22. ...Surgery remains the focus of current management although watchful waiting and occasionally radiation treat …
Neurofibromatosis type 2 (NF2) is an autosomal dominant inherited tumor predisposition syndrome caused by mutations in …
83 results